2006
DOI: 10.3182/20060402-4-br-2902.00485
|View full text |Cite
|
Sign up to set email alerts
|

Modelling of Hiv Infection: Vaccine Readiness, Drug Effectiveness and Therapeutical Failures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(14 citation statements)
references
References 24 publications
0
14
0
Order By: Relevance
“…−→ ∅ (13) Using reactions (1)-(13), we obtain the following model; (14) will be conducted using MATLAB. Parameters and initial conditions were obtained from previous works in the area Perelson [1999], Xia [2007], Conejeros et al [2007]. Using clinical data for the CD4+T cell counts Greenough [2000], Fauci et al [1996], some parameters were adjusted, see Table 1, in order to obtain the best match with clinical data.…”
Section: Virus Proliferationmentioning
confidence: 99%
“…−→ ∅ (13) Using reactions (1)-(13), we obtain the following model; (14) will be conducted using MATLAB. Parameters and initial conditions were obtained from previous works in the area Perelson [1999], Xia [2007], Conejeros et al [2007]. Using clinical data for the CD4+T cell counts Greenough [2000], Fauci et al [1996], some parameters were adjusted, see Table 1, in order to obtain the best match with clinical data.…”
Section: Virus Proliferationmentioning
confidence: 99%
“…Notice that, sinceà i is a Schur matrix, −à i + I is an M-matrix, whose inverse is a positive matrix, so that the vectors i in (39) are positive. The control rule (39) guarantees an upper bound on the cost function, i.e.…”
Section: Simulation Resultsmentioning
confidence: 99%
“…Note that typically during the treatment of HIV, clinical visits have a frequency of once a month or less. Using the parameter values of Table I and the control rule in (39), we see in Figure 3 that for an initial period of time, the switching rule maintains a low wild-type concentration and suppresses the concentrations of genotypes 1 and 2. However, the highly resistant genotype eventually grows since none of the therapies affect this genotype.…”
Section: Simulation Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…2) It can be seen that a model of such a simple nature is able to adequately reflect the disease progression from the initial infection to an asymptomatic stage after the set-point is reached (See [9]).…”
Section: Properties Of Hiv Basic Modelmentioning
confidence: 99%